Effects of lignocaine, propranolol and bretylium on ventricular fibrillation threshold.
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001949:Bretylium Compounds / Q000494:pharmacology*; D004285:Dogs; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008012:Lidocaine / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D011188:Potassium / Q000097:blood; D011433:Propranolol / Q000494:pharmacology*; D014693:Ventricular Fibrillation / Q000503:physiopathology*
D001949:Bretylium Compounds; D008012:Lidocaine; D011433:Propranolol; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D011188:Potassium; D010100:Oxygen